Latest Coronavirus Disease COVID 19 News and Research
Researchers develop a gentler and safer hair dye based on synthetic melanin
With the coronavirus pandemic temporarily shuttering hair salons, many clients are appreciating, and missing, the ability of hair dye to cover up grays or touch up roots.
Researchers test existing anti-inflammatory drug in COVID-19 patients
An anti-inflammatory drug developed at Scripps Research 25 years ago is now being tested as a way to prevent acute respiratory distress in patients with COVID-19, the pandemic disease caused by the novel coronavirus.
COVID tests are free, except when they’re not
Even before a novel virus swept around the world, Anna Davis Abel wore a mask to protect herself from getting sick.
The challenges of keeping young adults safe during the pandemic
Last month, after California Gov. Gavin Newsom ordered most of the state's residents to stay home, I found myself under virtual house arrest with an uncomfortably large number of Gen Zers.
BIOTECON Diagnostics releases microproof SARS-CoV-2 Screening/Identification Kits
BIOTECON Diagnostics has developed and launched its own microproof SARS-CoV-2 Screening/Identification Kits, which are available immediately for purchase and can be distributed globally.
UEA Health Sciences students and staff respond to the fight against COVID-19
Following a nationwide call for support for the NHS workforce, UEA students and staff have responded in their numbers, from undertaking placements to training former healthcare professionals who are re-joining the service at this time of national emergency.
GlobalData offers view on Gilead’s suspension of Covid-19 trials in China
Following the news that China trials of Gilead Sciences Inc’s antiviral drug remdesivir in patients with mild symptoms of coronavirus have been suspended due to lack of eligible patients;
Tapping into the powers of nature to identify virus killers
Many organisms have to defend themselves against predators, diseases or pests. Their metabolic products constitute a chemical arsenal that has been used for medical purposes since time immemorial.
_fcdd050324be4beea7934c07e2046430-150x125.jpg "Study with twins shows COVID-19 symptoms have genetic contribution")
Study with twins shows COVID-19 symptoms have genetic contribution
A new study published on the preprint server medRxiv from King's College, London, suggests that an individual's genetic makeup may contribute to how much a person is likely to be affected by COVID-19, or whether they are likely to be infected at all.
GlobalData: PPE shortage to drive adoption of robots to treat Covid-19 patients in India
Healthcare professionals are one of the most vulnerable groups exposed to infections. Rising number of coronavirus cases and severe shortage of personal protective equipment products across India are putting them at more risk.
_aeec4fdf73404d1b97e27fdce0b7880d-150x125.jpg "Study reveals SARS-CoV-2 RNA cap structure")
Study reveals SARS-CoV-2 RNA cap structure
A new study published on the preprint server bioRxiv in April 2020 reports the discovery of the structure of the cap created by the novel coronavirus on virally encoded mRNAs. The finding could help create new antiviral strategies.
'Smart sample pooling' for COVID-19 could solve test kit shortage problem
A new study from Pakistan suggests 'smart sample pooling' using population grouping with algorithms as a solution to the unavailability of test kits for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). SARS-CoV-2 is a virus that causes COVID-19 disease. The paper is published on the preprint server medRxiv on April 28, 2020.
How weather and demographics influence the COVID-19 spread
What can stop the spread of the novel coronavirus? A new study published in the preprint journal medRxiv in April 2020 debunks the idea that warmer and more humid conditions can hinder the pandemic from spreading with ease.
How toxic are chloroquine and hydroxychloroquine to cells?
The spread of the pandemic disease COVID-19 caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has now reached almost every country of the world, with over 3.11 million cases and over 217,000 deaths as of April 29, 2020.
Computer vision system detects fever remotely to rule out COVID-19
People who approach the front desk at Albert Einstein Jewish Hospital (HIAE) in the city of São Paulo have their temperature taken remotely by a computer vision system installed in a nearby column.
Study highlights biases and social implications in COVID-19 crisis
The biases individuals harbor against people they see as physically dirty emerge in children as young as five years old and persist into adulthood, according to a new study by researchers from Boston College and Franklin & Marshall College, who found these prejudices extend to the sick and may hold implications for people diagnosed with Covid-19.
Men are twice more likely to die of COVID-19 than women
There have been studies that have revealed that men are more likely to get more severe symptoms from COVID-19 disease and also more likely to die from complications of the disease. A new study corroborates these findings. The study titled, “Gender differences in patients with COVID-19: Focus on severity and mortality,” is published in the latest issue of the journal Frontiers in Public Health.
Epivax and Entos Pharmaceuticals to develop DNA-based vaccine for COVID-19
Entos Pharmaceuticals (Entos), a healthcare biotechnology company that develops next generation nucleic acid medicines using the Fusogenix drug delivery platform, today announced a collaboration with EpiVax, Inc. (EpiVax), a world leading informatics and immunology biotechnology company with a proven track record in vaccine development.
_0f44edeb04f24147bcf684c0f256f64a-150x125.jpg "French scientists suggest nicotinic agonists could treat COVID-19")
French scientists suggest nicotinic agonists could treat COVID-19
Contrary to the warnings issued by health agencies worldwide against cigarette smoking amid the coronavirus disease (COVID-19), a new paper suggests the possibility that nicotine, a component of tobacco, could prevent coronavirus infection.
COVID-19 could be causing potentially fatal inflammatory disease in children, doctors warn
Since the emergence of the coronavirus disease (COVID-19) in China in December 2019, health experts have cautioned that the disease is particularly serious in high-risk populations, including older adults, those with underlying diseases, and those who are immunocompromised. Now, doctors in the United Kingdom warn of a rare and severe inflammatory disease in children with COVID-19.
No hay comentarios:
Publicar un comentario